A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
10.1002/cam4.1001
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178675 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-178675 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1786752023-09-06T08:49:23Z A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma da Silveira Nogueira Lima, J.P Georgieva, M Haaland, B de Lima Lopes, G DUKE-NUS MEDICAL SCHOOL B Raf kinase carboplatin cobimetinib cytotoxic T lymphocyte antigen 4 dabrafenib dacarbazine ipilimumab mitogen activated protein kinase nivolumab paclitaxel pembrolizumab placebo programmed death 1 ligand 1 selumetinib temozolomide ticilimumab trametinib vemurafenib immunological antineoplastic agent Article cancer immunotherapy dosage schedule comparison drug dose comparison drug efficacy gene mutation human melanoma meta analysis molecularly targeted therapy overall survival priority journal progression free survival qualitative analysis randomized controlled trial (topic) systematic review disease free survival immunotherapy melanoma treatment outcome Antineoplastic Agents, Immunological Disease-Free Survival Humans Immunotherapy Melanoma Molecular Targeted Therapy Randomized Controlled Trials as Topic Treatment Outcome 10.1002/cam4.1001 Cancer Medicine 6 6 1143-1153 2020-10-21T07:52:04Z 2020-10-21T07:52:04Z 2017 Article da Silveira Nogueira Lima, J.P, Georgieva, M, Haaland, B, de Lima Lopes, G (2017). A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma. Cancer Medicine 6 (6) : 1143-1153. ScholarBank@NUS Repository. https://doi.org/10.1002/cam4.1001 20457634 https://scholarbank.nus.edu.sg/handle/10635/178675 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
B Raf kinase carboplatin cobimetinib cytotoxic T lymphocyte antigen 4 dabrafenib dacarbazine ipilimumab mitogen activated protein kinase nivolumab paclitaxel pembrolizumab placebo programmed death 1 ligand 1 selumetinib temozolomide ticilimumab trametinib vemurafenib immunological antineoplastic agent Article cancer immunotherapy dosage schedule comparison drug dose comparison drug efficacy gene mutation human melanoma meta analysis molecularly targeted therapy overall survival priority journal progression free survival qualitative analysis randomized controlled trial (topic) systematic review disease free survival immunotherapy melanoma treatment outcome Antineoplastic Agents, Immunological Disease-Free Survival Humans Immunotherapy Melanoma Molecular Targeted Therapy Randomized Controlled Trials as Topic Treatment Outcome |
spellingShingle |
B Raf kinase carboplatin cobimetinib cytotoxic T lymphocyte antigen 4 dabrafenib dacarbazine ipilimumab mitogen activated protein kinase nivolumab paclitaxel pembrolizumab placebo programmed death 1 ligand 1 selumetinib temozolomide ticilimumab trametinib vemurafenib immunological antineoplastic agent Article cancer immunotherapy dosage schedule comparison drug dose comparison drug efficacy gene mutation human melanoma meta analysis molecularly targeted therapy overall survival priority journal progression free survival qualitative analysis randomized controlled trial (topic) systematic review disease free survival immunotherapy melanoma treatment outcome Antineoplastic Agents, Immunological Disease-Free Survival Humans Immunotherapy Melanoma Molecular Targeted Therapy Randomized Controlled Trials as Topic Treatment Outcome da Silveira Nogueira Lima, J.P Georgieva, M Haaland, B de Lima Lopes, G A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
description |
10.1002/cam4.1001 |
author2 |
DUKE-NUS MEDICAL SCHOOL |
author_facet |
DUKE-NUS MEDICAL SCHOOL da Silveira Nogueira Lima, J.P Georgieva, M Haaland, B de Lima Lopes, G |
format |
Article |
author |
da Silveira Nogueira Lima, J.P Georgieva, M Haaland, B de Lima Lopes, G |
author_sort |
da Silveira Nogueira Lima, J.P |
title |
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
title_short |
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
title_full |
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
title_fullStr |
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
title_full_unstemmed |
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
title_sort |
systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/178675 |
_version_ |
1779152349520986112 |